Type I interferons and the Th1/Th2 paradigm

Developmental and Comparative Immunology

Volumn 23, Issue 7-8, 1999, Pages 657-663

  Sinigaglia, F ^a   D'Ambrosio, D ^a   Rogge, L ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

Cytokine signalling; IL 12; Interferon; Multiple sclerosis; Th1 cells; Th2 cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; INTERFERON; INTERLEUKIN 12; STAT4 PROTEIN;

ANTIGEN EXPRESSION; CELL DIFFERENTIATION; CELL TYPE; CYTOKINE RELEASE; HELPER CELL; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0032752698     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(99)00039-7     Document Type: Review

References (47)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. + T cells. Annu. Rev. Immunol. 12:1994;635-673.
3. Sinigaglia F, D'Ambrosio D, Panina-Bordignon P, Rogge L. Regulation of the IL-12/IL-12R axis: a critical step in T helper cell differentiation and effector function. Immunol Rev, in press.
4. Parronchi P., Mohapatra S., Sampognaro S., Giannarini L., Wahn U., Chong P.L., Mohapatra S., Maggi E., Ranz H., Romagnani S. Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur. J. Immunol. 26:(3):1996;697-703.
5. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825-832.
6. Wenner C.A., Guler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:(4):1996;1442-1447.
7. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature. 273:1978;759-761.
8. Parronchi P., De Carli M., Manetti R., Simonelli C., Sampognaro S., Piccini M.P., Macchia D., Maggi E., Del Prate G., Romagnani S. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. The Journal of Immunology. 149:1992;2977-2983.
9. + T cells. J. Exp. Med. 178:1993;1655-1663.
10. Rogge L., D'Ambrosio D., Biffi M., Penna G., Minetti L.J., Presky D.H., Adorini L., Sinigaglia F. The role of stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161:(12):1998;6567-6574.
11. Dayal A., Jensen M.A., Lledo A., Arnason B.G.W. Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 45:1995;2173-2177.
12. Zielinski R.M., Lawrence W.D. Interferon-α for the hyper-eosinophilic syndrome. Ann. Int. Med. 113:1990;716-718.
13. Butterfield J.H., Gleich G.J. Interferon-α treatment of 6 patients with the idiopathic hypereosinophillic syndrome. Ann. Int. Med. 121:1994;648-653.
14. Mackie R.M. Interferon-alpha for atopic dermatitis. Lancet. 335:1990;1282-1283.
15. Gruschwitz M.S., Peters K.P., Heese A., Stosiek N., Koch H.U., Hornstein O.P. Effects of interferon-alpha-2b on the clinical course, inflammatory infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema. Int. Arch. Allergy Immunol. 101:1993;20-30.
16. O'Garra A. Cytokine induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
17. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1992;1091-1098.
18. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T cell-receptor transgenic system. Proc. Natl Acad. Sci. USA. 89:1992;6065-6069.
19. Kopf M., Le Gros G., Bachmann M., Lamers M.C., Bluethmann H., Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 362:1993;245-248.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
21. + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA. 90:1993;10188-10192.
22. Manetti R., Gerosa F., Giudizi M.G., Biagiotti R., Parronchi P., Piccinni M-P., Sampognaro S., Maggi E., Romagnani S., Trinchieri G. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179:1994;1273-1283.
23. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C-Y., Ferrante J., Stewart C., Sarimiento U., Faherty D.A., Gately M.K. IL-12 deficient mice are defective in IFN-γ production and type I cytokine responses. Immunity. 4:1996;471-481.
24. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:1998;293-322.
25. Bacon C.M., Petricoin E.F. III, Ortaldo J.R., Rees R.C., Larner A.C., Johnston J.A., O'Shea J.J. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl Acad. Sci. USA. 92:1995;7307-7311.
26. Jacobson N.G., Szabo S.J., Weber-Nordt R.N., Zhong Z., Schreiber R.D., Darnell J.E., Murphy K.M. Interleukin 12 signalling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and 4. J. Exp. Med. 181:1995;1755-1762.
27. Szabo S.J., Jacobson N.G., Dighe A.S., Gubler U., Murphy K.M. Developmental commitment to the Th2 lineage by extinction of IL-12 signalling. Immunity. 2:(6):1995;665-675.
28. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A.A., Doherty P.C., Grosveld G.C., Ihle J.N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:1996;171-174.
29. Kaplan M.H., Sun Y.L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:(6587):1996;174-177.
30. Cho S.S., Bacon C.M., Sudarshan C., Rees R.C., Finbloom D., Pine R., O'Shea J.J. Activation of Stat4 by IL-12 and IFN-α. Evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:1996;4781-4789.
31. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:(5):1997;817-824.
32. Bonecchi R., Bianchi G., Panina Bordignon P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of Th1 and Th2 cells. J. Exp. Med. 187:1998;129-134.
33. Ho I.C., Lo D., Glimcher L.H. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188:(10):1998;1859-1866.
34. Zheng W-P., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:1997;587-596.
35. The I.F.N.B. Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:1993;655-661.
36. Rudick R., Goodkin D., Jacobs L., Cookfair D., Herndon R., Richert J., Salazar A., Fischer J., Granger C., Simon J., Alam J., Simonian N., Campion M., Bartoszak D., Bourdette D., Braiman J., Brownscheidle C., Coats M., Cohan S., Dougherty D., Kinkel R., Mass M., Munschauer F., Priore R., Whitham R., et al. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology. 49:1997;358-363.
37. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestations in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:1988;318-323.
38. Panitch H., Hirsch R., Haley R., Johnson K. Exacerbations of multiple sclerosis in patients with gamma interferon. Lancet. 1:1987;893-895.
39. Laman J. Balancing the Th1/Th2 concept in multiple sclerosis. Immunol. Today. 19:1998;489-490.
40. Cannella B., Raine C. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:(4):1995;424-435.
41. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.L. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 124:1989;132-143.
42. Dhib-Jalbut S. Mechanisms of interferon beta action in multiple sclerosis. Multiple Sclerosis. 3:1997;397-401.
43. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., Brennan M.B., Maloni H.W., McFarland H.F., Lin H-C., Patnaik M., Jacobson S. Association of human herpes virus 6 (HHV-6) with mutliple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1997;1394-1397.
44. Wong V.W., Chabot S., Stuve O., Williams G. Interferon beta in the treatment of multiple sclerosis. Neurology. 51:1998;682-689.
45. Leppert D., Waubant E., Burk M., Oksenberg J., Hauser S. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40:(6):1996;846-852.
46. Stuve O., Dooley N., Uhm J., Antel J., Francis G., Williams G., Yong V. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann. Neurol. 40:(6):1996;853-863.
47. Norga K., Paemen L., Masure S., Dillen C., Heremans H., Billiau A., Carton H., Cuzner L., Olsson T., Van Damme J. Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine. Inflamm. Res. 44:(12):1995;529-534.